
Chandra Bhagat Pharma Ltd
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- ₹119
- Today's High:
- ₹119
- Open Price:
- ₹119
- 52W Low:
- ₹83
- 52W High:
- ₹148.75
- Prev. Close:
- ₹116.1
- Volume:
- 1000
Company Statistics
- Market Cap.:
- ₹0
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Chandra Bhagat Pharma Ltd had its IPO on under the ticker symbol CBPL.
The company operates in the sector and industry. Chandra Bhagat Pharma Ltd has a staff strength of 0 employees.
Stock update
Shares of Chandra Bhagat Pharma Ltd opened at ₹119 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹119 - ₹119, and closed at ₹119.
This is a +2.5% increase from the previous day's closing price.
A total volume of 1,000 shares were traded at the close of the day’s session.
In the last one week, shares of Chandra Bhagat Pharma Ltd have slipped by -9.85%.
Chandra Bhagat Pharma Ltd's Key Ratios
Chandra Bhagat Pharma Ltd has a market cap of ₹0, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Chandra Bhagat Pharma Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Chandra Bhagat Pharma Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Chandra Bhagat Pharma Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q3.6666666666667, Chandra Bhagat Pharma Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Chandra Bhagat Pharma Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Chandra Bhagat Pharma Ltd’s profitability.
Chandra Bhagat Pharma Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Chandra Bhagat Pharma Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹0
- Total Liabilities
- ₹0
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Chandra Bhagat Pharma Ltd ended 1970 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.
Chandra Bhagat Pharma Ltd ended 1970 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Chandra Bhagat Pharma Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 1970, Chandra Bhagat Pharma Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Chandra Bhagat Pharma Ltd paid ₹0 in dividends in 1970.
Other key metrics
- Current Trading Price
- ₹119
- 52-Week High
- ₹148.75
- 52-Week Low
- ₹83
- Analyst Target Price
- ₹
Chandra Bhagat Pharma Ltd stock is currently trading at ₹119 per share. It touched a 52-week high of ₹148.75 and a 52-week low of ₹148.75. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹129.1 and 200-day moving average was ₹114.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.